Sebastien Monette

25PUBLICATIONS
226CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jun 15, 2026
Reprogramming of TLR-Ferroptosis Signaling and Immunometabolic Pathways Overcomes Myeloid Suppression to Improve Checkpoint Blockade in Prostate Cancer.

|Mar 10, 2026
Ultrastructural pathology and temporal patterns of viral replication and lesion development following mouse kidney parvovirus infection in B6, CD1, and NSG mice.

Ileana C Miranda, Mandy L Kain, Amanda C Ritter

|Jan 07, 2026
IL10R Inhibition Induces Neutrophil Tumoricidal Activity.

Danny N Khalil, Ricardo Gomez, Amit Regev

|Jan 02, 2026
Spontaneous and experimentally induced lesions in NOD-scid gamma and other NOD-derived mouse strains.

Pedro Ruivo, Renata Mammone, Ileana C Miranda

|Oct 22, 2024
Author Correction: Cancer-associated Histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation.

Benjamin A Nacev, Yakshi Dabas, Matthew R Paul

|Sep 09, 2024
A pan-cancer dye for solid-tumour screening, resection and wound monitoring via short-wave and near-infrared fluorescence imaging.

Benedict Edward Mc Larney, Ali Yasin Sonay, Elana Apfelbaum

Pageof 5

Frequent Collaborators

3 joint publications

Li Zhang

3 joint publications

Marcel R M van den Brink

3 joint publications

Darren Veach

3 joint publications

Samantha C St Jean